Zimmer Biomet Holdings, Inc. Website

Zimmer Biomet Holdings, Inc.

NYSE-ZBH

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

7,982.2

6,127.5

6,827.3

6,939.9

7,394.2

7,524.8

Total Revenues % Chg.

0.6%

-23.2%

11.4%

1.6%

6.5%

4.6%

Cost of Goods Sold, Total

2,198.7

1,824.3

1,960.4

2,019.5

2,083.8

2,122.6

Gross Profit

5,783.5

4,303.2

4,866.9

4,920.4

5,310.4

5,402.2

Selling General & Admin Expenses, Total

3,278.6

2,524.4

2,626.4

2,667.6

2,793

2,822.1

R&D Expenses

449.3

322.8

435.8

406

458.7

447.6

Amortization of Goodwill and Intangible Assets

584.3

512.1

529.5

526.8

561.5

576

Other Operating Expenses

—

—

—

—

—

82.4

50.9

52.8

33.8

—

—

Other Operating Expenses, Total

4,394.6

3,410.2

3,644.5

3,634.2

3,813.2

3,845.7

Operating Income

1,388.9

893

1,222.4

1,286.2

1,497.2

1,556.5

Interest Expense, Total

-226.9

-212.1

-208.4

-164.8

-201.2

-203.2

Interest And Investment Income

—

—

—

—

—

—

—

—

—

Net Interest Expenses

-226.9

-212.1

-208.4

-164.8

-201.2

-203.2

Currency Exchange Gains (Loss)

-14.4

-12.2

-5.5

-20.8

26

36.7

Other Non Operating Income (Expenses)

—

—

-2.9

13.7

1.7

-135.4

-59.5

-73.7

EBT, Excl. Unusual Items

1,144.7

682.4

1,010.2

965.2

1,262.5

1,316.3

Restructuring Charges

—

-50

-107.2

-125.7

-191.6

-151.9

-252.3

Merger & Related Restructuring Charges

—

—

—

—

—

4.6

Impairment of Goodwill

—

—

—

—

-470

—

-289.8

—

—

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

—

—

—

In Process R&D Expenses

—

—

—

-70.1

-33

-16.3

-3

—

—

Legal Settlements

—

—

—

-52.7

-166

-201

-65.9

-21.6

-24.9

Other Unusual Items

-66.1

-11.4

-168.2

-11.4

-21.7

-22.7

EBT, Incl. Unusual Items

905.8

-105.2

499

403.5

1,067.3

1,021

Income Tax Expense

-225.7

-96

53.5

112.3

42.2

22.6

Earnings From Continuing Operations

1,131.5

-9.2

445.5

291.2

1,025.1

998.4

Earnings Of Discontinued Operations

—

—

—

—

—

—

-128.2

-43.4

-58.8

—

—

Minority Interest

0.1

-1.5

-0.5

-1

-1.1

-1.3

Net Income

1,131.6

-138.9

401.6

231.4

1,024

997.1

Net Income to Common Incl Extra Items

1,131.6

-138.9

401.6

231.4

1,024

997.1

Net Income to Common Excl. Extra Items

1,131.6

-10.7

445

290.2

1,024

997.1

Total Shares Outstanding

206

207.6

209

209

205.6

204.9

Weighted Avg. Shares Outstanding

205.1

207

208.6

209.6

208.7

206.9

Weighted Avg. Shares Outstanding Dil

206.7

207

210.4

210.3

209.7

207.8

EPS

5.5

-0.7

1.9

1.1

4.9

4.8

EPS Diluted

5.5

-0.7

1.9

1.1

4.9

4.8

EBITDA

2,395

1,791.4

2,160.1

2,212.6

2,448.9

2,520.7

Effective Tax Rate

-24.9%

91.3%

10.7%

27.8%

4%

2.2%